Breaking News Instant updates and real-time market news.

RMED

Ra Medical Systems

$2.74

(0.00%)

07:44
08/13/19
08/13
07:44
08/13/19
07:44

Ra Medical Systems downgraded to Neutral from Overweight at Cantor Fitzgerald

RMED Ra Medical Systems
$2.74

(0.00%)

03/26/19
RHCO
03/26/19
NO CHANGE
Target $10
RHCO
Buy
Ra Medical Systems price target lowered to $10 from $16 at SunTrust
SunTrust analyst Bruce Nudell lowered his price target on Ra Medical Systems to $10 after its Q4 earnings miss reported last week. The analyst cites challenges that the company experienced with its catheter production ramp that dampened sales in Q4 and will impact revenues in Q1, including "manufacturing limitations due to problems with a specific piece of equipment in the production process." Nudell adds that Ra Medical Systems' sales rep hiring was also lower than expected because of the "stricter onboarding / training process put in place by the company's new Chief Commercial Officer, Thomas Fogarty." The analyst maintains his Buy rating with a positive longer term view for Ra Medical's peripheral vascular catheter sales.
05/14/19
PIPR
05/14/19
NO CHANGE
Target $9
PIPR
Overweight
Ra Medical beat expectations on most important metric, says Piper Jaffray
Ra Medical Systems reported Q1 results that beat the Street on the sales, which is the most important metric, Piper Jaffray analyst Matt O'Brien tells investors in a research note. Management did not provide guidance for Q2 or the year and is communicating to investors to look at Q3 as the proper measuring stick for its sales force realignment, which is not overly surprising as these changes always take longer than expected, adds the analyst. He finds it important that Ra Medical Systems has fixed its manufacturing problems and can now make as much product as demand it can generate. O'Brien believes risk-tolerant investors "should take a close look at the story" and reiterates an Overweight rating on Ra Medical, despite reducing his price target to $9 from $11.
05/15/19
MAXM
05/15/19
NO CHANGE
Target $12
MAXM
Buy
Ra Medical Systems price target lowered to $12 from $15 at Maxim
Maxim analyst Anthony Vendetti lowered his price target on Ra Medical Systems to $12, saying that while Q1 revenues topped expectations, earnings and gross margins missed due to manufacturing and production issues in the Vascular segment as well as higher SG&A expenses. The analyst keeps his Buy rating on the stock, but believes that the Vascular segment revenue ramp will "take some time."
08/13/19
PIPR
08/13/19
DOWNGRADE
Target $1.5
PIPR
Neutral
Ra Medical Systems downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Matt O'Brien downgraded Ra Medical Systems to Neutral from Overweight and lowered his price target for the shares to $1.50 from $9.00. Despite the dermatology business coming in ahead of expectations in Q2, the company's key vascular franchise came in well short of estimates, O'Brien tells investors in a research note. With the company delaying its quarterly results until the conclusion of an audit committee investigation based on an anonymous tip, and terminating its CEO, the analyst says the uncertainty outweighs his enthusiasm for Ra Medical's technology.

TODAY'S FREE FLY STORIES

10:40
08/21/19
08/21
10:40
08/21/19
10:40
General news
U.S. benchmark guidance »

U.S. benchmark guidance…

10:40
08/21/19
08/21
10:40
08/21/19
10:40
General news
Energy Action: WTI crude »

Energy Action: WTI crude…

MSGN

MSG Networks

$14.88

-1.97 (-11.69%)

10:36
08/21/19
08/21
10:36
08/21/19
10:36
Downgrade
MSG Networks rating change  »

Evercore ISI downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

SLNG

Stabilis Energy

$5.01

0.24 (5.03%)

10:34
08/21/19
08/21
10:34
08/21/19
10:34
Conference/Events
Stabilis Energy to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$101.73

16.16 (18.89%)

10:32
08/21/19
08/21
10:32
08/21/19
10:32
Upgrade
Target rating change at Wells Fargo »

Target upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

USO

United States Oil Fund

$11.79

0.15 (1.29%)

10:31
08/21/19
08/21
10:31
08/21/19
10:31
General news
Crude inventories for week of August 16 »

Crude oil inventories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$11.79

0.145 (1.25%)

10:30
08/21/19
08/21
10:30
08/21/19
10:30
Options
$5.8M straddle buy in US Oil ETF »

$5.8M straddle buy in US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WW

WW

$28.25

0.01 (0.04%)

10:25
08/21/19
08/21
10:25
08/21/19
10:25
Options
Weight Watchers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
08/21/19
08/21
10:25
08/21/19
10:25
General news
Treasury Action: the slight beat in existing home sales didn't really impact »

Treasury Action: the…

10:20
08/21/19
08/21
10:20
08/21/19
10:20
General news
The U.S. July existing home sales report beat estimates »

The U.S. July existing…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/21/19
08/21
10:17
08/21/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOOM

DMC Global

$42.78

1.375 (3.32%)

10:17
08/21/19
08/21
10:17
08/21/19
10:17
Conference/Events
DMC Global management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 13

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/21/19
08/21
10:16
08/21/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$49.57

-2.29 (-4.42%)

10:15
08/21/19
08/21
10:15
08/21/19
10:15
Options
AFLAC put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/21/19
08/21
10:15
08/21/19
10:15
General news
Breaking General news story  »

Week of 8/16 EIA…

HSGX

Histogenics

$0.22

0.0005 (0.23%)

10:14
08/21/19
08/21
10:14
08/21/19
10:14
Hot Stocks
Histogenics merger partner Ocugen granted FDA orphan designation »

Ocugen's treatment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYCN

Cyclerion Therapeutics

$9.59

0.8 (9.10%)

10:12
08/21/19
08/21
10:12
08/21/19
10:12
Upgrade
Cyclerion Therapeutics rating change  »

Cyclerion Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$49.65

-2.21 (-4.26%)

10:11
08/21/19
08/21
10:11
08/21/19
10:11
Recommendations
Aflac analyst commentary at Evercore ISI »

Aflac third sector sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLFD

Clearfield

$10.98

(0.00%)

, WSG

Wanda Sports

$4.12

0.22 (5.64%)

10:10
08/21/19
08/21
10:10
08/21/19
10:10
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

CLFD

Clearfield

$10.98

(0.00%)

WSG

Wanda Sports

$4.12

0.22 (5.64%)

INMB

INmune Bio

$6.30

0.46 (7.88%)

CLGX

CoreLogic

$47.28

0.49 (1.05%)

HUBB

Hubbell

$127.70

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 05

    Sep

  • 12

    Sep

  • 13

    Nov

CREE

Cree

$52.88

-5.31 (-9.13%)

, HA

Hawaiian Holdings

$23.94

-1.5 (-5.90%)

10:10
08/21/19
08/21
10:10
08/21/19
10:10
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

CREE

Cree

$52.88

-5.31 (-9.13%)

HA

Hawaiian Holdings

$23.94

-1.5 (-5.90%)

CIM

Chimera

$19.52

-0.17 (-0.86%)

SYBX

Synlogic

$3.25

-0.22 (-6.34%)

JAZZ

Jazz Pharmaceuticals

$134.12

-2.42 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 09

    Sep

  • 30

    Oct

NOW

ServiceNow

$263.94

8.44 (3.30%)

, EEX

Emerald Expositions Events

$9.73

0.24 (2.53%)

10:10
08/21/19
08/21
10:10
08/21/19
10:10
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

NOW

ServiceNow

$263.94

8.44 (3.30%)

EEX

Emerald Expositions Events

$9.73

0.24 (2.53%)

PSA

Public Storage

$261.11

0.66 (0.25%)

LSI

Life Storage

$104.00

0.68 (0.66%)

ONDK

On Deck Capital

$3.26

0.025 (0.77%)

RDFN

Redfin

$18.28

0.83 (4.76%)

RMAX

RE/MAX Holdings

$27.38

0.71 (2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 18

    Sep

  • 27

    Oct

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

10:10
08/21/19
08/21
10:10
08/21/19
10:10
General news
FX Action: The dollar »

FX Action: The dollar…

10:10
08/21/19
08/21
10:10
08/21/19
10:10
General news
U.S. July existing home sales rebounded 2.5% to 5.420 M »

U.S. July existing home…

PFE

Pfizer

$34.96

0.34 (0.98%)

10:03
08/21/19
08/21
10:03
08/21/19
10:03
Hot Stocks
Pfizer announces additional half billion dollar investment for Sanford facility »

Pfizer announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 16

    Sep

LKSD

LSC Communications

$1.34

0.01 (0.75%)

10:03
08/21/19
08/21
10:03
08/21/19
10:03
Hot Stocks
UBM acquires commingle operations from LSC Communications for $11.25M in cash »

LSC Communications and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.